Year archive

BIOME AUSTRALIA LIMITED — 2026 filings

All 30 regulatory filings released by BIOME AUSTRALIA LIMITED (BIO) in 2026, sourced directly from the official regulator.

30 Filings

2026 Period

2026 filings (30)

Filing	Released	Lang
Investor Webinar 3 pages 222.1KB Regulatory Filings	2026-05-26	English
BMB18 clinical trial expands to dual site 4 pages 170.9KB Regulatory Filings	2026-05-26	English
Probiotical Exclusive Supply Agreement Extended 3 pages 208.7KB Regulatory Filings	2026-05-11	English
Change of Director's Interest Notice 2 pages 335.6KB Director's Dealing	2026-04-29	English
Change of Director's Interest Notice 2 pages 335.9KB Director's Dealing	2026-04-28	English
Quarterly Activities & Cashflow Report 15 pages 1.6MB Interim / Quarterly Report Q3 2026	2026-04-27	English
Revised Appendix 4C Quarterly Cash Flow Report 16 pages 1.7MB Interim / Quarterly Report Q3 2026	2026-04-27	English
Patent Application Filed for Probiotic Strain BMB18 5 pages 204.0KB Regulatory Filings	2026-04-26	English
Change of Auditor 2 pages 164.0KB Board/Management Information	2026-04-09	English
Notification of cessation of securities - BIO 4 pages 14.6KB Share Issue/Capital Change	2026-03-31	English
Application for quotation of securities - BIO 6 pages 18.1KB Share Issue/Capital Change	2026-03-29	English
Secondary Trading Notice 1 page 135.2KB Regulatory Filings	2026-03-29	English
Application for quotation of securities - BIO 6 pages 18.2KB Share Issue/Capital Change	2026-03-19	English
Application for quotation of securities - BIO 7 pages 20.8KB Share Issue/Capital Change	2026-03-19	English
Secondary Trading Notice 1 page 135.5KB Capital/Financing Update	2026-03-19	English
Proposed issue of securities - BIO 5 pages 17.2KB Capital/Financing Update	2026-03-18	English
Application for quotation of securities - BIO 7 pages 21.0KB Share Issue/Capital Change	2026-03-16	English
Secondary Trading Notice 1 page 134.8KB Capital/Financing Update	2026-03-16	English
Change of Director's Interest Notice 2 pages 335.1KB Director's Dealing	2026-03-12	English
Application for quotation of securities - BIO 6 pages 18.1KB Share Issue/Capital Change	2026-03-11	English
Secondary Trading Notice 1 page 134.9KB Share Issue/Capital Change	2026-03-11	English
Expiry of Unlisted Options 2 pages 168.7KB Capital/Financing Update	2026-03-09	English
H1 FY26 Results & Company Presentation 25 pages 7.2MB Investor Presentation	2026-02-24	English
Appendix 4D & Half Yearly Report 20 pages 756.9KB Interim / Quarterly Report H1 2026	2026-02-22	English
Biome First Half FY26 Results and Highlights 7 pages 272.6KB Interim / Quarterly Report H1 2026	2026-02-22	English
Biome Half Year Results and Webinar 3 pages 166.0KB Regulatory Filings	2026-02-17	English
Ethics Approval Granted for BMB18 Human Clinical Trial 5 pages 179.0KB Regulatory Filings	2026-02-02	English
Biome secures distribution with Fullscript Canada 4 pages 252.2KB Regulatory Filings	2026-02-01	English
Quarterly Activities & Cashflow Report 14 pages 1.2MB Interim / Quarterly Report Q2 2026	2026-01-26	English
Trading Update 3 pages 296.8KB Earnings Release Q2 2026	2026-01-04	English